Serological screening for celiac disease, using endomysial antibodies, in patients with rheumatoid arthritis (notice n° 404568)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01790cam a2200241 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250119083930.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Ghozzi, Mariam |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Serological screening for celiac disease, using endomysial antibodies, in patients with rheumatoid arthritis |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2023.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 64 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Background and aims Celiac disease (CD) and rheumatoid arthritis (RA) are both multi-factorial chronic inflammatory auto-immune diseases. In this retrospective study, we determined the frequency of CD in patients with RA using IgA anti-endomysial antibodies (EmA) and attempted to explain this association. Patients and methods Indirect immunofluorescence on human umbilical cord was used to detect EmA in 215 patients with seropositive RA collected over a four-year-period. Two thousand five hundred healthy blood donors (HBDs) served as the control group. Results Among the 215 patients with RA, 12 (9 females) were found positive for EmA while only 7 were positive for EmA in the control group. The frequency of EmA was significantly higher in RA patients than in HBDs (5.58% vs. 0.28%, p Conclusion Patients with RA can be considered as a high-risk group for CD based on the high frequency of EmA positivity observed in our study. |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mechi, Fatma |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Salem, Alma Ben |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | El Ahmer, Ikram |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mbarki, Donia Rachel |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Melayah, Sarra |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mankai, Amani |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ghedira, Ibtissem |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Annales de Biologie Clinique | 81 | 6 | 2023-11-01 | p. 569-575 | 0003-3898 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/journal-annales-de-biologie-clinique-2023-6-page-569?lang=en&redirect-ssocas=7080">https://shs.cairn.info/journal-annales-de-biologie-clinique-2023-6-page-569?lang=en&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux